Coronavirus disease 2019 : changing the future of emergency epistaxis management
BACKGROUND: Acute epistaxis can be a life-threatening airway emergency, requiring in-patient admission. The coronavirus disease 2019 pandemic placed significant strain on hospital resources, and management has shifted towards an out-patient-centred approach.
METHODS: A five-month single-centre retrospective study was undertaken of all epistaxis patients managed by the ENT department. A pre-coronavirus disease 2019 pandemic group was managed with pre-existing guidelines, compared to new guidelines for the coronavirus disease 2019 pandemic group. A telephone survey was performed on out-patients with non-dissolvable packs to assess patient comfort and satisfaction.
RESULTS: A total of 142 patients were seen. The coronavirus disease 2019 pandemic group had significantly more patients aged over 65 years (p = 0.004), an increased use of absorbable dressings and local haemostatic agents (Nasopore and Surgiflo), and fewer admissions (all p < 0.0005). Rates of re-presentation and morbidity, and length of hospital stay were similar. The telephone survey revealed out-patient management to be efficacious and feasible.
CONCLUSION: The coronavirus disease 2019 pandemic has shifted epistaxis management towards local haemostatic agents and out-patient management; this approach is as safe and effective as previously well-established regimens.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:135 |
---|---|
Enthalten in: |
The Journal of laryngology and otology - 135(2021), 8 vom: 18. Aug., Seite 675-679 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Devabalan, Y [VerfasserIn] |
---|
Links: |
---|
Themen: |
Epistaxis |
---|
Anmerkungen: |
Date Completed 09.08.2021 Date Revised 09.08.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1017/S0022215121001456 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM325538611 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM325538611 | ||
003 | DE-627 | ||
005 | 20231225192645.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1017/S0022215121001456 |2 doi | |
028 | 5 | 2 | |a pubmed24n1085.xml |
035 | |a (DE-627)NLM325538611 | ||
035 | |a (NLM)34002682 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Devabalan, Y |e verfasserin |4 aut | |
245 | 1 | 0 | |a Coronavirus disease 2019 |b changing the future of emergency epistaxis management |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.08.2021 | ||
500 | |a Date Revised 09.08.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Acute epistaxis can be a life-threatening airway emergency, requiring in-patient admission. The coronavirus disease 2019 pandemic placed significant strain on hospital resources, and management has shifted towards an out-patient-centred approach | ||
520 | |a METHODS: A five-month single-centre retrospective study was undertaken of all epistaxis patients managed by the ENT department. A pre-coronavirus disease 2019 pandemic group was managed with pre-existing guidelines, compared to new guidelines for the coronavirus disease 2019 pandemic group. A telephone survey was performed on out-patients with non-dissolvable packs to assess patient comfort and satisfaction | ||
520 | |a RESULTS: A total of 142 patients were seen. The coronavirus disease 2019 pandemic group had significantly more patients aged over 65 years (p = 0.004), an increased use of absorbable dressings and local haemostatic agents (Nasopore and Surgiflo), and fewer admissions (all p < 0.0005). Rates of re-presentation and morbidity, and length of hospital stay were similar. The telephone survey revealed out-patient management to be efficacious and feasible | ||
520 | |a CONCLUSION: The coronavirus disease 2019 pandemic has shifted epistaxis management towards local haemostatic agents and out-patient management; this approach is as safe and effective as previously well-established regimens | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Epistaxis | |
650 | 4 | |a Hemostasis | |
650 | 4 | |a Patient Reported Outcome Measures | |
700 | 1 | |a Cereceda-Monteoliva, N |e verfasserin |4 aut | |
700 | 1 | |a Lorenz, H |e verfasserin |4 aut | |
700 | 1 | |a Magill, J C |e verfasserin |4 aut | |
700 | 1 | |a Unadkat, S |e verfasserin |4 aut | |
700 | 1 | |a Ferguson, M |e verfasserin |4 aut | |
700 | 1 | |a Rennie, C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of laryngology and otology |d 1945 |g 135(2021), 8 vom: 18. Aug., Seite 675-679 |w (DE-627)NLM000061794 |x 1748-5460 |7 nnns |
773 | 1 | 8 | |g volume:135 |g year:2021 |g number:8 |g day:18 |g month:08 |g pages:675-679 |
856 | 4 | 0 | |u http://dx.doi.org/10.1017/S0022215121001456 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 135 |j 2021 |e 8 |b 18 |c 08 |h 675-679 |